MedPath

Enhancement of Cognitive Behavioral therapy for anxiety disorders and posttraumatic stress disorder by bright light exposure

Not Applicable
Conditions
anxiety disorders and PTSD
Registration Number
JPRN-UMIN000023206
Lead Sponsor
Shiga University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
14
Inclusion Criteria

Not provided

Exclusion Criteria

1) Comorbid psychiatric disorders met in DSM-5 criteria. 2) Physical disorder diagnoses associated with the anxiety disorders or PTSD. 3) Severe suicidal ideation (C-SSRS: not less than 3). 4) Severe depressive symptoms (MADRS-S: 30 and over). 5) Pregnancy. 6) Retinal diseases.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
State Trait Anxiety Inventory (STAI)
Secondary Outcome Measures
NameTimeMethod
36-item short form of the MOS Questionnaire: SF-36 WHO Disability Schedule 2.0 (WHODAS 2.0) Montgomery-Asberg Depression Rating Scale (MADRS-S) Pittsburgh Sleep Quality Index (PSQI) Columbia-Suicide Severity Rating Scale: C-SSRS Alcohol Use Disorder Identification Test: AUDIT functional neuroimaging (fMRI) Liebowitz Social Anxiety Scale: LSAS-SR Panic Disorder Severity Scale: PDSS-SR Mobility Inventory for Agoraphobia: MIA Severity Measure for Specific Phobia-Adult: SMSP-A Impact of Event Scale Revised: IES-R
© Copyright 2025. All Rights Reserved by MedPath